Hgk Asset Management Inc Abbott Laboratories Transaction History

Hgk Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $278,240 - $326,419	2,927 Added 6.79%	46,024 $5.05 Million
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $423,518 - $490,355	-4,377 Reduced 9.22%	43,097 $4.17 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $1.14 Million - $1.37 Million	11,139 Added 30.66%	47,474 $5.16 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $157,347 - $191,875	-1,380 Reduced 3.66%	36,335 $4.3 Million
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $5,776 - $7,073	50 Added 0.13%	37,715 $5.31 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $160,057 - $177,070	1,372 Added 3.78%	37,665 $4.45 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $3.84 Million - $4.52 Million	36,293 New	36,293 $4.21 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Hgk Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Hgk Asset Management Inc with notifications on news.